The effectiveness and cost of exogenous pulmonary surfactant replacement therapy.
Smith
J
J
Pieper
C
C
Gie
R P
RP
D016527:Drug Costs; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy*; D007223:Infant; D007231:Infant, Newborn; D011663:Pulmonary Surfactants / Q000191:economics* / Q000627:therapeutic use*; D013019:South Africa; D016896:Treatment Outcome
D011663:Pulmonary Surfactants